Edgewell Personal Care Completes the Sale of its Feminine Care Business to Essity for $340M

Rhea-AI Summary

Edgewell Personal Care (NYSE: EPC) completed the sale of its feminine care business to Essity for $340 million on February 2, 2026. Edgewell plans to use net proceeds, after taxes and transaction costs, primarily to strengthen its balance sheet and pay down its U.S. revolving credit facility.

The companies signed a Transition Services Agreement for at least one year to support accounting, IT, quality, operations, supply chain, and sales. Edgewell will report the feminine care business as a discontinued operation and expects a Form 8-K with pro forma financials on or before February 6, 2026; supplemental details will be provided in the First Quarter Fiscal 2026 earnings call on February 9, 2026.

Positive

• $340 million in sale proceeds from feminine care divestiture
• Proceeds earmarked to pay down U.S. revolving credit facility
• Transition Services Agreement in place for at least one year
• Company to file pro forma financials on Form 8-K on or before Feb 6, 2026

Negative

• Feminine care business classified as a discontinued operation
• Sale reduces Edgewell's product portfolio diversification away from feminine care

News Market Reaction – EPC

+0.51%

1 alert

+0.51% News Effect

On the day this news was published, EPC gained 0.51%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Sale proceeds: $340 million Form 8-K timing: On or before Feb 6, 2026 Earnings call date: Feb 9, 2026 +1 more

4 metrics

Sale proceeds $340 million Consideration for Feminine Care business sale to Essity

Form 8-K timing On or before Feb 6, 2026 Expected filing date for pro forma financial information

Earnings call date Feb 9, 2026 First Quarter Fiscal 2026 earnings call

Transition period length At least one year Transition Services Agreement support duration from closing

Market Reality Check

Price: $21.13 Vol: Volume 666,041 is 1.14x t...

normal vol

$21.13 Last Close

Volume Volume 666,041 is 1.14x the 20-day average of 586,497, indicating slightly elevated trading interest pre-news. normal

Technical Shares at 19.46 are trading below the 200-day MA of 22.38, despite a 3.02% daily gain.

Peers on Argus

EPC gained 3.02% on the feminine care divestiture completion while peers showed ...

1 Up

EPC gained 3.02% on the feminine care divestiture completion while peers showed mixed, more modest moves (e.g., HELE in momentum scanner up about 7.19% without news). With only one peer in momentum and no common headlines, the move appears company-specific.

Historical Context

5 past events · Latest: Jan 12 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	Earnings call scheduling	Neutral	+1.1%	Announcement of Q1 FY2026 earnings release and webcast timing details.
Dec 08	Sustainability initiative	Neutral	-4.9%	Launch of free Schick and Skintimate razor recycling program with TerraCycle.
Nov 25	Conference appearance	Neutral	+0.5%	Planned fireside chat at Morgan Stanley Global Consumer and Retail Conference.
Nov 13	Earnings and outlook	Neutral	-2.8%	FY2025 results, FY2026 outlook, capital return, and confirmation of $340M segment sale.
Nov 12	Business divestiture deal	Positive	+1.8%	Agreement to sell Feminine Care business to Essity for $340M with reinvestment plans.

Pattern Detected

Recent company-specific announcements (including the original sale agreement) tended to see small, generally positive price reactions, while brand/ESG news produced a weaker or negative response.

Recent Company History

Over the past several months, Edgewell has telegraphed this portfolio shift. On Nov 12, 2025, it announced the agreement to sell its Feminine Care business for $340M, with a positive price reaction. The subsequent 10-K reiterated the $340M divestiture as a major portfolio reshaping step. Earnings on Nov 13, 2025 highlighted mixed fundamentals but confirmed the sale and a new repurchase program. Today’s news confirms closing of the same transaction, consistent with this ongoing transformation narrative.

Market Pulse Summary

This announcement confirms closing of the $340 million sale of Edgewell’s Feminine Care business to ...

Analysis

This announcement confirms closing of the $340 million sale of Edgewell’s Feminine Care business to Essity and reiterates plans to focus on shave, sun and skin care, and grooming. It follows earlier disclosures of the deal and portfolio shift in prior news and the 10-K. Investors may track how proceeds are applied to the balance sheet, upcoming pro forma financials on Form 8-K, and the February 9, 2026 earnings call for details on the company’s post-divestiture profile.

Key Terms

revolving credit facility, transition services agreement, regulation s-x, form 8-k, +2 more

6 terms

revolving credit facility financial

"pay down the balance of U.S. revolving credit facility while continuing"

A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.

transition services agreement regulatory

"The Company and Essity entered into a Transition Services Agreement to provide"

A transition services agreement is a formal arrangement where one company continues to provide essential services—such as IT, human resources, or accounting—to another company after a business deal or change in ownership. It acts like a temporary bridge, ensuring smooth operations during a transition period. For investors, it provides clarity on how long support will last and helps assess potential costs and stability during the change.

regulation s-x regulatory

"financial information prepared in accordance with Article 11 of Regulation S-X"

A set of U.S. securities rules that prescribes how public companies must prepare, present and have audited their financial statements and related exhibits. It lays out formats, required schedules and minimum disclosure standards so financial reports follow a consistent structure. For investors, this consistency and verification act like a standard recipe and inspection checklist, making financial statements easier to compare, trust and use for valuation decisions.

form 8-k regulatory

"made available to investors in a Current Report on Form 8-K on or before"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

discontinued operation financial

"reflect the sale of the Feminine Care business as a discontinued operation."

A discontinued operation is a part of a company that has been sold, closed, or is planned to be shut down, and will no longer be part of its ongoing business activities. For investors, it matters because it can significantly affect a company's financial results and future outlook, similar to removing a large, ongoing project from a company's operations. Recognizing discontinued operations helps investors better understand a company's current performance separate from parts that are no longer active.

pro forma condensed consolidated financial information financial

"This pro forma condensed consolidated financial information is expected to be"

Pro forma condensed consolidated financial information presents a company's combined, summarized financial results adjusted to show how a recent or proposed transaction—such as a merger, acquisition, divestiture, or restructuring—would have affected revenue, expenses and assets if it had occurred earlier. Investors use this 'what if' snapshot to judge the potential impact of that event and to compare performance across periods, but it relies on assumptions and is not always the same as audited statements.

AI-generated analysis. Not financial advice.

SHELTON, Conn., Feb. 2, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced that it has completed the sale of its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for $340 million. Edgewell intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet and pay down the balance of U.S. revolving credit facility while continuing to invest in the long-term growth of its core businesses.

"Completing the sale of our Feminine Care business is a pivotal step in Edgewell's transformation. By simplifying our portfolio and focusing our resources on shave, sun and skin care, and grooming, we are positioning Edgewell to be a more focused, agile and durable personal care company," said Edgewell President and CEO Rod Little. "The proceeds from this transaction will strengthen our balance sheet, support debt reduction and reinvestment behind our core brands and innovation pipeline, as we look to drive sustainable growth and long‑term value for shareholders, while our Feminine Care colleagues gain new opportunities as part of Essity, a global leader in health and hygiene."

Edgewell expects to work closely with Essity to ensure a smooth transition for employees, customers, and consumers of the Feminine Care business. The Company and Essity entered into a Transition Services Agreement to provide certain support services in the areas of accounting, information technology, quality assurance, operations and supply chain, and sales for a period of at least one year from the closing of the transaction.

The Company will provide unaudited condensed consolidated financial information prepared in accordance with Article 11 of Regulation S-X to reflect the sale of the Feminine Care business as a discontinued operation. This pro forma condensed consolidated financial information is expected to be made available to investors in a Current Report on Form 8-K on or before February 6, 2026, while additional supplemental financial information will be provided during the Company's First Quarter Fiscal 2026 earnings call on February 9, 2026.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our anticipated uses of net proceeds from the transaction, anticipated benefits of the transaction to us and our stakeholders, and our strategy, future financial results, and competitive position. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, our ability to compete in products and prices, as well as costs, in an intensely competitive industry; the loss of any of our principal customers or changes in the policies of our principal customers; our inability to design and execute a successful omnichannel strategy; our ability to attract, retain and develop key personnel; fluctuations in the price and supply of raw materials and costs of labor, warehousing and transportation; as well as the other factors described in our Annual Report on Form 10-K for the year ended September 30, 2025, and as may be updated in the Company's other filings with the Securities and Exchange Commission. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

About Edgewell Personal Care
Edgewell is a leading pure-play consumer products company with an attractive, diversified portfolio of established brand names such as Schick®, Wilkinson Sword® and Billie® men's and women's shaving systems and disposable razors; Edge and Skintimate® shave preparations; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack Black®, and CREMO® sun and skin care products; and Wet Ones® products. The Company has a broad global footprint and operates in more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,700 employees worldwide.

View original content to download multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-completes-the-sale-of-its-feminine-care-business-to-essity-for-340m-302676559.html

SOURCE Edgewell Personal Care Company

FAQ

How much did Edgewell (EPC) receive for the sale of its feminine care business on February 2, 2026?

Edgewell received $340 million from the sale. According to the company, net proceeds after taxes and transaction costs will primarily be used to strengthen the balance sheet and pay down the U.S. revolving credit facility.

What will Edgewell (EPC) do with the proceeds from the feminine care sale?

Edgewell intends to use proceeds mainly to reduce debt and reinforce its balance sheet. According to the company, funds will primarily pay down the U.S. revolving credit facility and support reinvestment in core brands and innovation.

Will Edgewell (EPC) remain involved with the feminine care business after the February 2, 2026 closing?

Edgewell will provide transition support under a services agreement for at least one year. According to the company, the Transition Services Agreement covers accounting, IT, quality, operations, supply chain, and sales support during the handover.

When will Edgewell (EPC) provide financial details for the feminine care sale and its impact?

Edgewell expects to file pro forma financials on Form 8-K on or before February 6, 2026. According to the company, additional supplemental financial information will be provided on the First Quarter Fiscal 2026 earnings call on February 9, 2026.

How will the feminine care sale be recorded in Edgewell's financial statements for 2026?

The feminine care business will be reported as a discontinued operation. According to the company, unaudited condensed consolidated financial information will be prepared under Article 11 of Regulation S-X to reflect the sale.